Tubulin is retained throughout the human hematopoietic/erythroid cell differentiation process and plays a structural role in sedimentable fraction of mature erythrocytes

Int J Biochem Cell Biol. 2017 Oct;91(Pt A):29-36. doi: 10.1016/j.biocel.2017.08.012. Epub 2017 Sep 1.

Abstract

We investigated the properties of tubulin present in the sedimentable fraction ("Sed-tub") of human erythrocytes, and tracked the location and organization of tubulin in various types of cells during the process of hematopoietic/erythroid differentiation. Sed-tub was sensitive to taxol/nocodazole (drugs that modify microtubule assembly/disassembly), but was organized as part of a protein network rather than in typical microtubule form. This network had a non-uniform "connected-ring" structure, with tubulin localized in the connection areas and associated with other proteins. When tubulin was eliminated from Sed-tub fraction, this connected-ring structure disappeared. Spectrin, a major protein component in Sed-tub fraction, formed a complex with tubulin. During hematopoietic differentiation, tubulin shifts from typical microtubule structure (in pro-erythroblasts) to a disorganized structure (in later stages), and is retained in reticulocytes following enucleation. Thus, tubulin is not completely lost when erythrocytes mature; it continues to play a structural role in the Sed-tub fraction.

Keywords: Enucleation; Erythrocyte; Hematopoietic differentiation pathway; Sedimentable fraction; Tubulin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Blood Sedimentation / drug effects
  • Erythrocytes / cytology*
  • Erythrocytes / drug effects
  • Erythrocytes / metabolism*
  • Female
  • Hematopoiesis* / drug effects
  • Humans
  • Male
  • Nocodazole / pharmacology
  • Paclitaxel / pharmacology
  • Spectrin / metabolism
  • Tubulin / chemistry
  • Tubulin / metabolism*

Substances

  • Tubulin
  • Spectrin
  • Paclitaxel
  • Nocodazole